| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/30/2006 | EP1696028A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/30/2006 | EP1696027A1 Hla-dr-binding antigen peptide derived from wt1 |
| 08/30/2006 | EP1695986A2 Anti-erb B2 antibodies |
| 08/30/2006 | EP1695985A2 Humanized antibodies and methods for forming humanized antibodies |
| 08/30/2006 | EP1695080A1 Method for determining embryo quality |
| 08/30/2006 | EP1695059A2 Method for sex biasing spermatozoa |
| 08/30/2006 | EP1694856A1 Methods, compositions, and automated systems for separating rare cells from fluid samples |
| 08/30/2006 | EP1694848A1 Novel chimeric plasminogen activators and their pharmaceutical use |
| 08/30/2006 | EP1694844A2 Methods for producing olfactory gpcrs |
| 08/30/2006 | EP1694830A2 Novel atypical pneumonia-causing virus |
| 08/30/2006 | EP1694828A1 Serum-free vero cell banking process |
| 08/30/2006 | EP1694827A1 Methods for clonal derivation of human blastocyst-derived stem cell lines |
| 08/30/2006 | EP1694826A1 Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers |
| 08/30/2006 | EP1694825A2 Methods of generating stem cells and embryonic bodies carrying disease-causing mutations and methods of using same for studying genetic disorders |
| 08/30/2006 | EP1694712A1 Modified macromolecules and methods of making and using thereof |
| 08/30/2006 | EP1694708A2 Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and use |
| 08/30/2006 | EP1694707A1 Human anti-idiotypic antibody fragments that mimic her-2/neu |
| 08/30/2006 | EP1694706A2 Modified anti-cd52 antibody |
| 08/30/2006 | EP1694364A2 System for treating and preventing breast cancer |
| 08/30/2006 | EP1694354A1 Method for preventing and treating diabetes using neurturin |
| 08/30/2006 | EP1694352A2 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 08/30/2006 | EP1694309A2 Artificial synapse chip |
| 08/30/2006 | EP1694118A1 Tissue preservation media |
| 08/30/2006 | EP1644502A4 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 08/30/2006 | EP1569510A4 Microfluidic device for cell separation and uses thereof |
| 08/30/2006 | EP1532247A4 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof |
| 08/30/2006 | EP1501350A4 Activation of equine oocytes |
| 08/30/2006 | EP1497444A4 Methods for increasing polypeptide production |
| 08/30/2006 | EP1490477A4 Redifferentiated cells for repairing cartilage defects |
| 08/30/2006 | EP1434872A4 Bbc3 gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter |
| 08/30/2006 | EP1432790A4 Regulation of cytotrophoblast cell differentiation and cell migration |
| 08/30/2006 | EP1423524B1 Method of protein production in plants |
| 08/30/2006 | EP1375668B1 Vegetative growth-specific promoter and genetically modified plants obtained thereby |
| 08/30/2006 | EP1334188B1 Cd19-specific redirected immune cells |
| 08/30/2006 | EP1297011B1 Diagnostic uses of the t-cell protein tzon7, and of the peptides and antibodies derived therefrom |
| 08/30/2006 | EP1294898B1 FATTY ACID ELONGASE 3-KETOACYL CoA SYNTHASE POLYPEPTIDES |
| 08/30/2006 | EP1266015B1 Ecdysone receptor-based inducible gene expression system |
| 08/30/2006 | EP1266008B1 Acute neuronal induced calcium binding protein type 1 ligand |
| 08/30/2006 | EP1230343B1 Aspegillus niger beta-glucosidase gene, protein and uses thereof |
| 08/30/2006 | EP1210430B1 Muc-1 derived peptides |
| 08/30/2006 | EP1180524B1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
| 08/30/2006 | EP1151088B1 Improved phytases |
| 08/30/2006 | EP1133558B1 Compositions and methods for increasing bone mineralization |
| 08/30/2006 | EP1037900A4 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
| 08/30/2006 | EP0972036B1 Prion propagation inhibition by dominant-negative prion protein mutants |
| 08/30/2006 | EP0909316B1 Glial cell line-derived neurotrophic factor receptor |
| 08/30/2006 | EP0531498B1 Production of plants resistant to attacks of sclerotinia sclerotiorum by introducing a gene coding for an oxalate oxidase |
| 08/30/2006 | CN1826411A Promoter construct for gene expression in neuronal cells |
| 08/30/2006 | CN1826409A Synthetic gene encoding human epidermal growth factor 2/NEU antigen and uses thereof |
| 08/30/2006 | CN1826406A Production of poxviruses with adherent or non adherent avian cell lines |
| 08/30/2006 | CN1826405A Method of repairing primate mammalian tissue |
| 08/30/2006 | CN1826360A Thermosensitive polymers for therapeutic use and methods of preparation |
| 08/30/2006 | CN1826356A Binding molecules against sars-coronavirus and uses thereof |
| 08/30/2006 | CN1824789A Preparation of testis specific protein 50 monoclonal antibody and polyclonal antibody and use |
| 08/30/2006 | CN1824779A Soyabean thermal excited transcryption factor, its coding gene and application |
| 08/30/2006 | CN1824778A Tomato anti insect related gene, its coding protein and application |
| 08/30/2006 | CN1824773A Human testicle specificity protein 50 gene expression regulator screening system and method of screening its gene expression regulator |
| 08/30/2006 | CN1824772A Shell and tube orientation arrangement structure cell holder and its preparation method |
| 08/30/2006 | CN1824771A Bone marrow matrix cell transfectioned by human promoting blood vascular poietin gene and its use |
| 08/30/2006 | CN1824770A Treatment method for biological erythrocyte volume long time stabilization |
| 08/30/2006 | CN1824310A Preparation method of medicine for treating pelada |
| 08/30/2006 | CN1823581A Continuous culture of conifer embryogenic tissue |
| 08/30/2006 | CN1272440C Use and constructing method for anticancer recombined gland virus with tumor cell PLK1 as target of medicine |
| 08/30/2006 | CN1272432C Method fornursing and culturing plant protoplast |
| 08/30/2006 | CN1272345C Silensed anti-CD 28 antibodies and use thereof |
| 08/29/2006 | US7098390 Hybrid maize 33M72 |
| 08/29/2006 | US7098388 Nucleotide sequences affecting plant male fertility and methods of using same |
| 08/29/2006 | US7098385 Soybean cultivar 4916816 |
| 08/29/2006 | US7098384 seeds of soybean plants; crossbreeding and hybridization confers resistance to herbicides, disease, male sterility |
| 08/29/2006 | US7098383 Methods for the production of multimeric immunoglobulins, and related compositions |
| 08/29/2006 | US7098376 Expression vector coding constitutively active hydrocarbon receptor (CA-AhR) for generating animal models which screen and identify antitumor/anticarcinogenic agents |
| 08/29/2006 | US7098375 Animal and cell models for type II diabetes and their use |
| 08/29/2006 | US7098316 Isolated nucleic acid, coding regions of genes of proteins, vectors, host cells and genetic engineering for producing proteins and diagnosis of diseaes |
| 08/29/2006 | US7098313 DNA sequences coding for a polyol carrier and their use, in particular for the preparation of transgenic plants |
| 08/29/2006 | US7098191 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
| 08/29/2006 | US7098190 Formulations comprising antisense nucleotides to connexins |
| 08/29/2006 | US7098184 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 08/29/2006 | US7098183 cell growth differentiation factors/polypeptides for immunization; animal models |
| 08/29/2006 | US7098031 Random integration of a polynucleotide by in vivo linearization |
| 08/29/2006 | US7098029 Product and method for control of obesity |
| 08/29/2006 | US7098028 Preparing in vitro cell cultures utilizing self assembling macroscopic membranes for use as slow-diffusion drug delivery systems, artificial skin, separation matrices and animal model for alzheimer's and viral diseases |
| 08/29/2006 | US7098027 Bone marrow or cord blood cells transplanted into rat animal model comprised of demyelinated axons in order to remyelinate defective nervous system tissues; gene therapy and neurodegenerative disorders |
| 08/29/2006 | US7098026 Human desert hedgehog protein |
| 08/29/2006 | US7098025 Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor |
| 08/29/2006 | US7098020 DNA encoding hydantoinase, DNA encoding N-carbamyl-L-amino acid hydrolase, recombinant DNA, transformed cell, method of producing protein, and method of producing optically active amino acid |
| 08/29/2006 | US7098013 used for formation of cyclotetrasaccharide from a saccharide with a glucose polymerization degree of 3 or higher; genetic engineering |
| 08/29/2006 | US7098011 chimeric sequences encoding all or a substantial portion of the enzymes, in sense or antisense orientation, wherein expression of the chimeric sequence results in production of altered levels of the enzyme in a transformed host cell |
| 08/29/2006 | US7098001 Polypeptides having dipeptidyl aminopeptidase activity and nucleic acids encoding same |
| 08/29/2006 | US7097994 UDP-N-acetylglucosamine:galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GaINAc) β1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 08/29/2006 | US7097991 screening for an agent that modulates capsaicin receptor function |
| 08/29/2006 | US7097986 For use in pharmaceutical and diagnostic formulations |
| 08/29/2006 | US7097985 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 08/29/2006 | US7097977 Target of anticancer agent |
| 08/29/2006 | US7097972 invention provides non-naturally occurring and isolated naturally occurring nucleic acid molecules which code proteins designated Yama Pro-Yama and non-naturally occurring nucleic acid molecule coding mutant CrmA protein and dominant inhibitory Yama.Vectors and host cells containing these nucleic acids |
| 08/29/2006 | US7097970 Screening for modulators of viral infections; obtain cells, incubate with modulators, transfect cells, evaluate viral infective activity |
| 08/29/2006 | US7097965 Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein |
| 08/29/2006 | US7097846 35 kD tumor associated protein antigen: uses and methods of detection |
| 08/29/2006 | US7097834 Osteoprotegerin binding proteins |
| 08/29/2006 | US7097833 Increasing blood flow to regenerate and prevent cardiac failure in tissue experiencing ischemic events; neovasculaization; tissue engineering |
| 08/29/2006 | US7097832 Intramyocardial injection of autologous bone marrow |